Company news

Valeo Pharma Inc. news in 2024

Valeo Pharma Inc.'s news releases, calls and decks from 2024, newest first.

View company

Valeo Pharma reports third quarter 2024 revenues

September 11, 2024

Valeo Pharma to host third quarter 2024 results conference call / webcast

September 8, 2024

Valeo Pharma amends credit facility with sagard healthcare royalty partners, lp

September 2, 2024

Valeo Pharma announces voluntary delisting from OTCQB venture market

August 28, 2024

Valeo Pharma announces leadership changes

August 5, 2024

Valeo Pharma announces senior executive appointment and board of directors change

June 17, 2024

Valeo Pharma reports record second quarter 2024 revenues

June 12, 2024

Valeo Pharma announces restructuring of commercial field operations to support path to profitability

June 12, 2024

Valeo Pharma to host second quarter 2024 results conference call / webcast

June 3, 2024

Valeo Pharma announces results of annual meeting of shareholders

April 24, 2024

Valeo Pharma to present at the 2024 bloom burton & co healthcare investor conference

April 8, 2024

Valeo Pharma announces appointment of Mr. Al Moghaddam to board of directors

March 21, 2024

Valeo Pharma reports first quarter 2024 results

March 13, 2024

Valeo Pharma to host first quarter 2024 results conference call / webcast

March 6, 2024

Valeo Pharma announces board of directors changes

February 12, 2024

Valeo Pharma amends agreement with novartis pharmaceuticals canada for (pr)XIIDRA® in canada and credit facility with sagard healthcare royalty partners, lp

February 1, 2024

Valeo Pharma reports record annual revenues for fiscal year 2023

January 28, 2024

Valeo Pharma to host fourth quarter and year-end 2023 results conference call / webcast

January 21, 2024

Decks in 2024